Radium-223 in Prostate Cancer REPLY

被引：33
|
作者：
Parker, Chris [1 ]
Sartor, Oliver [2 ]
机构：
[1] Royal Marsden Hosp, Sutton, Surrey, England
[2] Tulane Univ, Sch Med, New Orleans, LA 70112 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 369卷 / 17期
关键词：
D O I：
10.1056/NEJMc1310231
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
To the Editor: In their editorial on the use of radium-223 for the treatment of bone metastases in prostate cancer, Vapiwala and Glatstein (July 18 issue)(1) provide an overview of the benefits of alpha-emitting radioisotopes. They focus on the results reported in the same issue of the Journal by Parker et al.,(2) who describe the association between the use of radium-223 dichloride and an observed increase in survival, as compared with placebo. In both the article and the editorial, the authors suggest that current radiopharmaceutical agents for bone pain palliation do not prolong survival, with the editorialists stating that the ...
引用
收藏
页码：1659 / 1660
页数：2
相关论文
共 50 条
  • [31] The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer
    Wilson, James M.
    Parker, Christopher
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 911 - 918
  • [32] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [33] Radium-223 for men with hormone-refractory prostate cancer and bone metastases
    Shelley, Mike D.
    Mason, Malcolm D.
    LANCET ONCOLOGY, 2007, 8 (07): : 564 - 565
  • [34] Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer
    de Jong, Anouk C.
    Isebia, Khrystany T.
    Ling, Sui Wai
    de Weerd, Vanja
    Van, Ngoc M.
    Kraan, Jaco
    Martens, John W. M.
    Mehra, Niven
    Hamberg, Paul
    Lolkema, Martijn P.
    de Wit, Ronald
    van der Veldt, Astrid A. M.
    Wilting, Saskia M.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [35] Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
    Modi, Dipenkumar
    Hwang, Clara
    Mamdani, Hirva
    Kim, Seongho
    Gayar, Hesham
    Vaishampayan, Ulka
    Joyrich, Richard
    Heath, Elisabeth I.
    CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 373 - 380
  • [36] Use of Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer
    Parker, Chris
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 723 - 725
  • [37] Radium-223 in the therapeutic sequence of metastatic castration-resistant prostate cancer
    Unda-Urzaiz, M.
    Sousa-Campo, R.
    Rodriguez-Antolin, A.
    Silva-Marins, C.
    Juarez-Soto, A.
    Minana-Lopez, B.
    Figueiredo-de Castro, A.
    Cozar-Olmos, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (04): : 227 - 237
  • [38] Radium-223 and metastatic prostate cancer: new insights from cellular studies
    Marques, I. A.
    Abrantes, A. M.
    Neves, A. R.
    Pires, A. S.
    Costa, G.
    Caramelo, F.
    Rodrigues, T.
    Matafome, P.
    Tavares-Silva, E.
    Seica, R.
    Figueiredo, A.
    Botelho, M. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S769 - S769
  • [39] Efficacy of radium-223 dichloride in castration-resistant metastatic prostate cancer
    Sobrevilla Calvo, Pedro de Jesus
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 26 - 27
  • [40] Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer
    Maughan, Benjamin L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 764 - 766
12345